Viatris Stock On Fire: Up 6.9% With 8-Day Winning Streak
Viatris (VTRS) stock hit day 8 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 6.9% return. The company has gained about $786 Mil in value over the last 8 days, with its current market capitalization at about $12 Bil. The stock remains 13.1% below its value at the end of 2024. This compares with year-to-date returns of 13.9% for the S&P 500.
VTRS provides pharmaceuticals and biosimilars across multiple therapeutic areas, distributing products through wholesalers, retailers, institutional, mail-order, e-commerce, and specialty pharmacies globally. After this rally, is VTRS still a buy – or is it time to lock in gains? Deep dive with Buy or Sell VTRS.
A single stock can be risky, but there is a huge value to a broader, diversified approach we take with the Trefis High Quality Portfolio. Trefis works with Empirical Asset Management — a Boston area wealth manager — whose asset allocation strategies yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Empirical has incorporated the Trefis HQ Portfolio in this asset allocation framework to provide clients with higher returns while taking on lower levels of risk versus the benchmark index.
Comparing VTRS Stock Returns With The S&P 500
The following table summarizes the return for VTRS stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | VTRS | S&P 500 |
|---|---|---|
| 1D | 0.2% | -0.5% |
| 8D (Current Streak) | 6.9% | 2.2% |
| 1M (21D) | 8.4% | 0.6% |
| 3M (63D) | 12.6% | 5.3% |
| YTD 2025 | -13.1% | 13.9% |
| 2024 | 19.7% | 23.3% |
| 2023 | 2.1% | 24.2% |
| 2022 | -14.3% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has VTRS behaved after prior drops? See VTRS Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 74 S&P constituents with 3 days or more of consecutive gains and 21 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 12 | 11 |
| 4D | 45 | 4 |
| 5D | 12 | 5 |
| 6D | 2 | 0 |
| 7D or more | 3 | 1 |
| Total >=3 D | 74 | 21 |
Key Financials for Viatris (VTRS)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $15.4 Bil | $14.7 Bil |
| Operating Income | $983.3 Mil | $389.3 Mil |
| Net Income | $54.7 Mil | $-634.2 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $3.3 Bil | $3.6 Bil |
| Operating Income | $-8.9 Mil | $185.4 Mil |
| Net Income | $-3.0 Bil | $-4.6 Mil |
While VTRS stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.